• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by AltPep Corporation

    News headline image
    AltPep Corporation Presents New Preclinical Data at CTAD 2025 Demonstrating SOBIN-AD, its Custom-Designed Peptide for Alzheimer’s Disease, Improves Behavior in Both Symptomatic and Asymptomatic Disease
    From AltPep Corporation
    Via Business Wire
    News headline image
    AltPep Corporation Presents New Preclinical Data at AAIC 2025 Demonstrating SOBIN-AD, its Custom-Designed Peptide for Alzheimer’s Disease, Increases Clearance of Aβ Toxic Oligomers and Inhibits Plaque Formation
    From AltPep Corporation
    Via Business Wire
    News headline image
    AltPep Corporation Appoints Alan Colowick, M.D., M.P.H. to Board of Directors
    From AltPep Corporation
    Via Business Wire
    News headline image
    AltPep Corporation Welcomes Denis Sirringhaus as Vice President of Business Development
    From AltPep Corporation
    Via Business Wire
    News headline image
    AltPep Study Published in Nature Journal, Scientific Reports, Further Affirms Potential of Blood Test to Detect Alzheimer's Disease
    From AltPep Corporation
    Via Business Wire
    News headline image
    AltPep Appoints Soon Hyouk Lee to Newly Created Position of Chief Business Officer
    From AltPep Corporation
    Via Business Wire
    News headline image
    AltPep Further Strengthens Advisory Board with Appointment of Steven E. Kahn, M.B., Ch.B.
    From AltPep Corporation
    Via Business Wire
    News headline image
    AltPep Corporation Announces Close of $53 Million Series B Financing to Advance Its Novel Therapeutics for both Alzheimer’s and Parkinson’s Diseases into the Clinic
    From AltPep Corporation
    Via Business Wire
    News headline image
    AltPep Strengthens Advisory Board with Three Leading Experts in Alzheimer’s Disease and Neurodegenerative Disorders
    From AltPep Corporation
    Via Business Wire
    News headline image
    A New Study in the Proceedings of the National Academy of Sciences (PNAS) Demonstrates the Ability of a Novel Peptide to Selectively Detect and Neutralize an Early Molecular Trigger of Alzheimer’s and Other Neurodegenerative Diseases
    From AltPep Corporation
    Via Business Wire
    News headline image
    AltPep Appoints Nancy Hill to Newly Created Position of Chief Product Officer
    From AltPep Corporation
    Via Business Wire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.